Sanginita Chemicals Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für Sanginita Chemicals zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Chemicals earnings growth | 19.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Revenues Working Against Sanginita Chemicals Limited's (NSE:SANGINITA) Share Price Following 26% Dive
Mar 11Sanginita Chemicals Limited (NSE:SANGINITA) Surges 38% Yet Its Low P/S Is No Reason For Excitement
Jan 02These 4 Measures Indicate That Sanginita Chemicals (NSE:SANGINITA) Is Using Debt Reasonably Well
Dec 30Sanginita Chemicals (NSE:SANGINITA) Seems To Use Debt Quite Sensibly
Sep 05Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?
Dec 13We Think Sanginita Chemicals (NSE:SANGINITA) Is Taking Some Risk With Its Debt
Feb 15Sanginita Chemicals (NSE:SANGINITA) Has A Somewhat Strained Balance Sheet
Jul 22Is Sanginita Chemicals (NSE:SANGINITA) Using Too Much Debt?
Mar 16Sanginita Chemicals Limited's (NSE:SANGINITA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18Does Sanginita Chemicals (NSE:SANGINITA) Have A Healthy Balance Sheet?
Nov 26In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanginita Chemicals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 1,323 | 13 | N/A | N/A | N/A |
9/30/2023 | 1,367 | 11 | 81 | 102 | N/A |
6/30/2023 | 1,334 | 6 | N/A | N/A | N/A |
3/31/2023 | 1,486 | 4 | 128 | 137 | N/A |
12/31/2022 | 1,535 | 0 | N/A | N/A | N/A |
9/30/2022 | 1,720 | -9 | 26 | 29 | N/A |
6/30/2022 | 1,918 | -3 | N/A | N/A | N/A |
3/31/2022 | 1,981 | 3 | -36 | -30 | N/A |
12/31/2021 | 2,127 | 7 | N/A | N/A | N/A |
9/30/2021 | 1,977 | 12 | 47 | 53 | N/A |
6/30/2021 | 1,953 | 17 | N/A | N/A | N/A |
3/31/2021 | 1,648 | 8 | 82 | 85 | N/A |
12/31/2020 | 1,486 | 6 | N/A | N/A | N/A |
9/30/2020 | 1,567 | 20 | 22 | 24 | N/A |
6/30/2020 | 1,462 | 24 | N/A | N/A | N/A |
3/31/2020 | 1,598 | 34 | -24 | -16 | N/A |
12/31/2019 | 1,648 | 50 | N/A | N/A | N/A |
9/30/2019 | 1,589 | 44 | N/A | N/A | N/A |
6/30/2019 | 1,748 | 38 | N/A | N/A | N/A |
3/31/2019 | 1,876 | 39 | -3 | 6 | N/A |
3/31/2018 | 1,945 | 35 | 17 | 28 | N/A |
3/31/2017 | 1,473 | 11 | N/A | -74 | N/A |
3/31/2016 | 1,441 | 11 | N/A | 2 | N/A |
3/31/2015 | 1,286 | 10 | N/A | 23 | N/A |
3/31/2014 | 1,190 | 8 | N/A | 57 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von SANGINITA über der Sparquote liegt (6.7%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von SANGINITA schneller wachsen werden als der Markt Indian
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von SANGINITA in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von SANGINITA schneller wachsen werden als der Markt von Indian.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von SANGINITA schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von SANGINITA in 3 Jahren voraussichtlich hoch sein wird